China Oncology

Loading...

Welcome to China Oncology,

China Oncology

30 January 2015, Volume 25 Issue 1 Previous Issue Next Issue

The role of gap junctions composed of connexin 43 on the anti-tumor effect induced by etoposide

WANG Lingzhi, PENG Jianxin, TAO Liang et al

2015, 25 (1): 1-5. doi: 10.3969/j.issn.1007-3969.2015.01.001

Abstract ( 813) PDF (1223KB) ( 1205 )

Silencing of miR-21 influences the function of colon cancer cell line HT-29 and the expression of PDCD4

REN Yupeng, SONG Chun, ZHANG Hao

2015, 25 (1): 6-12. doi: 10.3969/j.issn.1007-3969.2015.01.002

Abstract ( 355) PDF (2286KB) ( 830 )

Expression of CCL26 in esophageal squamous cell carcinoma tissues and its clinical significance

YANG Xiaodong, QIAO Junjing, QIN Yanru

2015, 25 (1): 13-18. doi: 10.3969/j.issn.1007-3969.2015.01.003

Abstract ( 281) PDF (1296KB) ( 779 )

Quantitative analysis of LMX1A and PAX1 gene methylation in cervical cancer and cervical intraepithelial neoplasia

CHEN Wei, YANG Huijuan, XU Jun et al

2015, 25 (1): 19-24. doi: 10.3969/j.issn.1007-3969.2015.01.004

Abstract ( 395) PDF (1962KB) ( 1043 )

The role of Δ133p53 during 5-FU inhibition experiments on the growth of gastric cancer cell line MKN45

GUO Ai, JI Wansheng, JIANG Qiqi et al

2015, 25 (1): 25-30. doi: 10.3969/j.issn.1007-3969.2015.01.005

Abstract ( 305) PDF (2830KB) ( 831 )

Effects of oridonin on cytoskeletal protein F-actin in human pancreatic carcinoma cells

LIU Junlou, SHEN Hong, XU Li et al

2015, 25 (1): 31-37. doi: 10.3969/j.issn.1007-3969.2015.01.006

Abstract ( 264) PDF (2547KB) ( 833 )

Resistance reverse effect of anemoside B4 and tetrandrine on oxaliplatin-resistant human colon cancer cells and the mechanism

LI Min, FANG Mingzhi

2015, 25 (1): 38-44. doi: 10.3969/j.issn.1007-3969.2015.01.007

Abstract ( 268) PDF (995KB) ( 849 )

Distribution of 5-FU in rat hepatoma, liver tissue and plasma after locoregional infusion

ZHENG Jinglei, LIANG Lijian, WANG Zaiguo et al

2015, 25 (1): 45-49. doi: 10.3969/j.issn.1007-3969.2015.01.008

Abstract ( 268) PDF (1062KB) ( 811 )

The clinical analysis of retreatment with erlotinib in advanced non-small cell lung cancer

WU Biao, HUANG Cheng, JIANG Kan et al

2015, 25 (1): 50-55. doi: 10.3969/j.issn.1007-3969.2015.01.009

Abstract ( 274) PDF (1123KB) ( 973 )

Analysis of the effects of different treatment methods in patients with stage Ⅰb2 bullky cervical cancer

HAN Nana, SHAO Wenyu, LIU Kaijiang et al

2015, 25 (1): 56-62. doi: 10.3969/j.issn.1007-3969.2015.01.010

Abstract ( 287) PDF (1181KB) ( 931 )

Clinical observation of albumin-bound paclitaxel plus S-1 in patients with advanced pancreatic cancer after the failure of gemcitabine

PENG Xiaobo, YAN Fang, WANG Bin et al

2015, 25 (1): 63-66. doi: 10.3969/j.issn.1007-3969.2015.01.011

Abstract ( 461) PDF (1023KB) ( 1648 )

The survey of cancer treatment model and staging in mainland China

WU Yu, JIANG Minjue, JIA Huixun et al

2015, 25 (1): 67-72. doi: 10.3969/j.issn.1007-3969.2015.01.012

Abstract ( 475) PDF (1035KB) ( 1304 )

Update on the molecular targeted therapy for cervical cancer

YANG Li, CHENG Xi

2015, 25 (1): 73-80. doi: 10.3969/j.issn.1007-3969.2015.01.013

Abstract ( 374) PDF (1134KB) ( 2046 )

中国癌症杂志

Database Indexing

A Guide to the Core Journals of China
Chinese Science Citation Database (CSCD)
China National Knowledge Infrastructure (CNKI)
Chinese Sci-tech Paper and Citation Database (CSTPCD)
Outsanding S&T Journals of China (2020) (F5000)
World Journal Clout Index (WJCI) Report of Scientific and Technological Periodicals (2021)
SCOPUS
EMBASE
DOAJ
Chemical Abstracts (CA)
Japan Science and Technology Database (JST)
The Western Pacific Region Index Medicus (WPRIM)
EBSCO
Index of Copernicus International (ICI)

Competent Authorities

　The Ministry of Education of the People’s Republic of China

Sponsored by

　Fudan University Shanghai Cancer Center

Edited by

　Editorial Board of China Oncology

Editor-in-Chief

　SHAO Zhimin

Honorary Editor-in-Chief

　TANG Zhaoyou, CAO Shilong, SHEN Zhenzhou

Printed by

　Shanghai Ouyang Printing Co., Ltd.

WeChat